End-of-day quote
Other stock markets
|
||
- | - |
05-21 | Sector Update: Health Care Stocks Advance Late Afternoon | MT |
05-21 | China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK | DJ |
Sales 2024 * | 60.41B 0 82.55B | Sales 2025 * | 62.7B 0 85.69B | Capitalization | 162B 0 221B |
---|---|---|---|---|---|
Net income 2024 * | 7.78B - 10.63B | Net income 2025 * | 11.29B - 15.43B | EV / Sales 2024 * | 3.64 x |
Net Debt 2024 * | 58.11B 0 79.42B | Net Debt 2025 * | 49.97B 0 68.28B | EV / Sales 2025 * | 3.38 x |
P/E ratio 2024 * |
19.9
x | P/E ratio 2025 * |
13.9
x | Employees | - |
Yield 2024 * |
5.91% | Yield 2025 * |
6.04% | Free-Float | 59.05% |
Latest transcript on PFIZER
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
1st Jan change | Capi. | |
---|---|---|
+37.78% | 723B | |
+30.87% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.53% | 244B | |
-4.54% | 208B | |
+10.12% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- PFE Stock
- PFZ Stock